Osteoporosis in pediatrics

Israel Medical Association Journal

Volumn 5, Issue 7, 2003, Pages 509-515

  Hartman, Corina ^a,b   Hochberg, Zeev ^a,b   Shamir, Raanan ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Bone mineral density; Childhood; Osteoporosis; Peak bone mass

Indexed keywords

ALCOHOL; ALUMINUM SALT; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; COLLAGEN TYPE 1; CYCLOSPORIN A; CYTOKINE; ESTROGEN; GLUCOCORTICOID; GONADORELIN AGONIST; HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LITHIUM SALT; MEDROXYPROGESTERONE ACETATE; MERCAPTOPURINE; METHOTREXATE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PEPTIDE; PHOSPHORUS; PREDNISONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID; THYROID HORMONE; TUMOR NECROSIS FACTOR RECEPTOR; UNINDEXED DRUG; VITAMIN D;

BLOOD DISEASE; BONE DENSITY; BONE DISEASE; BONE GROWTH; BONE MARROW TRANSPLANTATION; BONE MASS; BONE MINERAL; BONE REMODELING; CELIAC DISEASE; CHILDHOOD DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EATING DISORDER; ECHOGRAPHY; ENDOCRINE DISEASE; ENTERITIS; ESTROGEN THERAPY; GASTROINTESTINAL DISEASE; HUMAN; JUVENILE OSTEOPOROSIS; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY DISEASE; LEUKEMIA; LIVER TRANSPLANTATION; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PEDIATRICS; PRIMARY PREVENTION; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATOID ARTHRITIS; SECONDARY PREVENTION; ADOLESCENT; AGE; BONE DEVELOPMENT; CHILD; PHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; AGE FACTORS; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; HUMANS; OSTEOPOROSIS;

EID: 0042567226     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. National Osteoporosis Foundation. Osteoporosis: Review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporosis Int 1998;8(Suppl.4):S1-88.
2. Jee WSS. Introduction to skeletal function: Structural and metabolic aspects. In Bronner F, Worrell RV. eds. A Basic Science Primer in Orthopedics. Baltimore: Williams & Wilkins 1991:3-34.
3. Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-11.
4. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000;15:2-12.
5. Baas S. The differing tempo of growth in bone size, mass and density in girls is region specific. J Clin Invest 1999;104:795-804.
6. Kerrigan JR, Rogol AD. The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. Endocr Rev 1992;13:281-98.
7. Eisman JA. Genetics of osteoporosis. Endocr Rev 1999;20:788-804.
8. Matkovic V, Kostial K, Simonovic I, Buzina R, Brodarec A, Nordin BEC. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutr 1979;32:540-9.
9. Lee WT, Leung SS, Lui SS, Lau J. Relationship between long-term calcium intake and bone mineral content of children aged from birth to 5 years. Br J Nutr 1993;70:235-48.
10. Cumming RG, Nevitt MC. Calcium for prevention of osteoporotic fractures in postmenopausal women. J Bone Miner Res 1997;12:1321-9.
11. Baker SS, Cochran WJ, Flores CA, et al. American Academy of Pediatrics. Committee on Nutrition. Calcium requirements in infants, children and adolescents. Calcium requirements in infants, children and adolescents. Pediatrics 1999;104:1152-7.
12. Mazess RB, Barden HS, Ohlrich ES. Skeletal and body composition effects of anorexia nervosa. Am J Clin Nutr 1990;52:483-41.
13. Zamora SA, Rizzoli R, Belli DC, Slosman DO, Bonjour JP. Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab 1999;84:4541-4.
14. Hunter D, Major P, Arden N, et al. A randomized controlled trial of vitamin D supplementation on preventing postmenopausal bone loss and modifying bone metabolism using identical twin pairs. J Bone Miner Res 2000;15:2276-83.
15. Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A. Vitamin D metabolism and action. Osteoporosis Int 1998 (Suppl.8):S13-S19.
16. Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001;86:5217-21.
17. Ishimi Y, Miyaura C, Ohmura M, et al. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 1999;140:1893-900.
18. Szulc P, Seeman E, Delmas PD. Biochemical measurements of bone turnover in children and adolescents. Osteoporosis Int 2000;11:281-94.
19. Gilsanz V. Bone density in children: A review of the available techniques and indications. Eur J Radiol 1998;26:177-82.
20. Ellis KJ, Shypailo RJ, Hardin DS, et al. Z score prediction model for assessment of bone mineral content in pediatric disease. J Bone Miner Res 2001;16:1658-64.
21. Mølgaard C, Thomsen BL, Prentice A, Cole TJ, Michaelsen KF. Whole body mineral content in healthy children and adolescents. Arch Dis Child 1997:76:9-15.
22. Rauch F, Travers R, Norman ME, Taylor A, Parfitt AM, Glorieux FH. Deficient bone formation in idiopathic juvenile osteoporosis: A histomorphometric study of cancellous iliac bone. J Bone Miner Res 2001;15:957-63.
23. Elsasser U, Wilkins B, Hesp R, Thurnham DI, Reeve J, Ansell BM. Bone rarefaction and crush fractures in juvenile chronic arthritis. Arch Dis Child 1982;57:377-80.
24. Joffe I, Epstein S. Osteoporosis associated with rheumatoid arthritis: Pathogenesis and management. Semin Arthritis Rheum 1991;20:256-72.
25. Bianchi ML, Cimaz R, Bardane M, et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue disease in children: A prospective multicenter study. Arthritis Rheum 2000;43:1960-6.
26. Semeao EJ, Jawad AF, Stouffer NO, Zemel BS, Piccoli DA, Stallings VA. Risk factors for low bone mineral density in children and young adults with Crohn's disease. J Pediatr 1999;135L593-600.
27. Boot AM, Bouquet J, Krenning EP, De Muinck Keizer-Scrama SMPF. Bone mineral density and nutritional status in children with inflammatory bowel disease. Gut 1998;42:188-94.
28. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirshner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998;114:902-11.
29. Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut 2000;46(Suppl 1):11-18.
30. Valdimarsson T, Toss G, Ross I, et al. Bone mineral density in celiac disease. Scand J Gastroenterol 1994;29:457-61.
31. Meyer D, Stavropolous S, Diamond B, Shane E, Green PH. Osteoporosis in a North American population with celiac disease. Am J Gastroenterol 2001;96:112-19.
32. Mora S, Weber G, Barera G, et al. Effect of gluten free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr 1993;57:224-8.
33. Laursen EM, Molgaard C, Michaelsen KF, Koch C, Muller J. Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child 1999;81:235-40
34. Bhudhikanok GS, Wang MC, Marcus R, Harkins A, Moss RB, Bachrach LK. Bone acquisition and loss in children and adults with cystic fibrosis: A longitudinal study. J Pediatr 1998;133:18-27.
35. Saito JK, Davis JW, Wasnich RD, Ross PD. Users of low-dose glucocorticoids have increased bone loss rates: A longitudinal study. Calcif Tissue Int 1995;57:115-19.
36. Reid IR. Steroid-induced osteoporosis. Osteoporosis Int 1997;7(Suppl 3):S213-16.
37. American College of Rheumatology ad hoc Committee on glucocorticoid-induced osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 2001;44:1496-503.
38. Wallach S, Cohen S, Reid DM, et al. Effects of risendronate treatment on bone mineral density and vertebral fractures in patients on corticosteroid therapy. Calcif Tissue Int 2000;67:277-85.
39. Allgrove J. Bisphosphonates. Arch Dis Child 1997;76:73-5.